Table 2.
The committee | Year | Age (years) | Threshold to initiate medical therapy | Target of BP control | Class of recommendations | Level of evidence |
---|---|---|---|---|---|---|
NICE | 2011 | >80 | BP >160/100 mmHg | BP <150/90 mmHg | N/A | N/A |
<80 | BP >140/90 mmHg | BP <140/90 mmHg | N/A | N/A | ||
ESH and ESC | 2013 | >80 | SBP >160 mmHg | SBP between 140 and 150 mmHg | Strong | High |
<80 | SBP >140 mmHg | SBP <140 mmHg | Moderate | Low | ||
JNC 8 | 2014 | >60 | BP >150/90 mmHg | BP <150/90 mmHg | Strong | Moderate to high |
CHEP | 2016 | >80 | SBP >160 mmHg | SBP <150 mmHg | N/A | Low |
75-80 | SBP >130 mmHg | SBP <120 mmHg | N/A | Moderate | ||
ACP and AAFP | 2017 | >60 | SBP >150 mmHg | SBP <150 mmHg | Strong | High |
SBP >140 mmHg for patients with a history of stroke or TIA | SBP <140 | Weak | Moderate | |||
SBP >140 mmHg for patients at high cardiac risk | <140 | Weak | Low | |||
Many societies including AHA/ACC, ASH, and AGS | 2017 | >65 | BP >130/80 | BP <130/80 | Strong | High |
AAFP: American Academy of Family Physicians, ACC: American College of Cardiology, ACP: American College of Physicians, AGS: American Geriatric Society, AHA: American Heart Association, BP: Blood pressure, CHEP: Canadian Hypertension Education Program, ESC: European Society of Cardiology, ESH: European Society of Hypertension, JNC 8: Eighth Joint National Committee, N/A: Not available, NICE: National Institute of Health and Care Excellence, SBP: Systolic blood pressure, ASH: American Society of Hypertension, TIA: Transient ischemic attack